Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urine screening with the MS-2.

D J Hoban, J C Koss, C A Gratton

    Journal of Clinical Microbiology
    |June 1, 1983
    PubMed
    Summary

    This study compared the MS-2 system's ability to detect bacteria in urine samples with traditional methods. Researchers evaluated 15,319 samples, including midstream and catheter specimens. The MS-2 system performed well at high bacterial concentrations but showed lower accuracy at lower colony counts. A software update improved some detection rates but also caused slight declines in others. The findings suggest that automated systems like the MS-2 are effective for high-concentration samples but may need additional tools for low-concentration cases. The study highlights the importance of using complementary diagnostic methods in clinical settings.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Does conventional early life academic excellence predict later life scientific discovery? An assessment of the lives of great medical innovators.

    QJM : monthly journal of the Association of Physicians·2020
    Same author

    Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential.

    The Journal of antimicrobial chemotherapy·2017
    Same author

    In vitro activity of tigecycline and comparators against carbapenem-resistant Enterobacteriaceae in Africa-Middle East countries: TEST 2007-2012.

    Journal of global antimicrobial resistance·2016
    Same author

    Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013).

    Antimicrobial agents and chemotherapy·2015
    Same author

    In vitro activity of tigecycline against isolates collected from complicated skin and skin structure infections and intra-abdominal infections in Africa and Middle East countries: TEST 2007-2012.

    Diagnostic microbiology and infectious disease·2014
    Same author

    In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012.

    Antimicrobial agents and chemotherapy·2014

    Area of Science:

    • Clinical microbiology diagnostics
    • Urology specimen analysis
    • Medical laboratory automation

    Background:

    Clinical laboratories rely on accurate and efficient methods to screen urine specimens for bacterial contamination. Prior research has shown that automated systems can improve diagnostic speed and consistency. However, the effectiveness of these systems at varying bacterial concentrations remains unclear. This uncertainty drove the need to assess the MS-2 system's performance in detecting bacterial growth across different colony-forming unit thresholds. Established methods like surface streaking remain standard but may lack the throughput needed for high-volume labs. No prior work had resolved how well automated systems detect low bacterial loads in clinical samples. This gap motivated a direct comparison between the MS-2 and traditional techniques. The study aimed to clarify detection rates at multiple concentration ranges. It was already known that midstream and catheter specimens differ in contamination risk. That uncertainty drove the inclusion of both specimen types in the analysis. Researchers needed to determine if software updates improved detection accuracy.

    Keywords:
    Urine bacterial contaminationClinical laboratory diagnosticsAutomated urine testingColony-forming unit analysis

    Frequently Asked Questions

    The MS-2 system is an automated diagnostic tool used to detect bacterial growth in urine specimens. It evaluates colony-forming unit concentrations to identify contamination.

    The MS-2 system detected 94.5% of midstream specimens with colony counts above 10^5 CFU/ml, while surface streaking remains a traditional manual method.

    Midstream and catheter specimens differ in contamination risk, so researchers evaluated them separately to assess detection accuracy across specimen types.

    The software update in phase II slightly reduced detection rates at lower colony counts but improved accuracy at 5-10^4 CFU/ml for catheter specimens.

    Related Experiment Videos

    Purpose Of The Study:

    The study aimed to evaluate the MS-2 system's ability to detect bacterial growth in urine specimens compared to a surface streak method. Researchers focused on midstream and catheter specimens, which differ in contamination likelihood. The goal was to measure detection rates at various colony-forming unit thresholds. The analysis included two phases to assess the impact of a software update. The primary objective was to determine if the MS-2 system could reliably identify bacterial growth across a wide range of concentrations. The study sought to compare performance between specimen types and phases. Researchers also aimed to quantify detection accuracy at low colony counts. This work addressed a gap in understanding how automated systems perform in real-world clinical settings.

    Main Methods:

    The study evaluated 15,319 urine specimens using the MS-2 system and a surface streak procedure. Specimens were divided into midstream and catheter categories. The analysis occurred in two phases, with phase II using updated software (03.01). Detection rates were measured at five colony-forming unit ranges. The system's performance was compared against traditional streaking methods. Researchers calculated detection percentages for each concentration range. Data collection included both qualitative and quantitative assessments. The study design allowed for direct comparison between phases and specimen types.

    Main Results:

    For midstream specimens, the MS-2 detected 94.5% of samples with colony counts above 10^5 CFU/ml in phase I. In phase II, detection dropped slightly to 94.3%. At 5-10^4 CFU/ml, detection rates were 74.4% and 65.3% in phases I and II. For 1-5×10^4 CFU/ml, rates were 55.0% and 52.4%. At 10^3-10^4 CFU/ml, detection was 31.2% and 20.5%. For counts below 10^3 CFU/ml, rates were 15.7% and 6.4%. Catheter specimens showed similar trends but with slightly higher detection rates at higher concentrations.

    Conclusions:

    The MS-2 system demonstrated high detection rates for midstream and catheter specimens at colony counts above 10^5 CFU/ml. Detection rates decreased as bacterial concentrations dropped below 10^5 CFU/ml. The software update in phase II slightly reduced detection at some concentration ranges. The system's performance varied between specimen types and concentration ranges. Researchers observed a decline in detection accuracy at lower colony counts. The study confirmed the MS-2's effectiveness in high-concentration scenarios. The findings suggest that automated systems may struggle with low bacterial loads. The results highlight the need for complementary methods at lower concentration thresholds.

    The study tested detection rates at five ranges: >10^5, 5-10^4, 1-5×10^4, 10^3-10^4, and <10^3 CFU/ml.

    The findings suggest that automated systems like the MS-2 may require supplementary methods for accurate detection at low bacterial concentrations.